Drug Eruption and Interactions - PHARMACEUTICAL REVIEW

516 SULFITES
(2000): Sanchez-Perez J+, Contact Dermatitis 42(3), 176 (SM in
antihemorrhoidal cream)
(1999): Tucker SC+, Contact Dermatitis 40(3), 164 (MS in
Trimovate)
(1997): Nagayama H+, JDermatol24(10), 675 (SB in Tathion
eye drops)
(1996): Pambor M, Contact Dermatitis 35(1), 48 (AB in bleaching
cream)
(1995): Jacobs MC+, Contact Dermatitis 33(1), 65 (SM)
(1994): Bonneau JC, Allerg Immunol (Paris) 26(9), 324
(1994): Vena GA+, Contact Dermatitis 31(3), 172 (PM, SB, SS)
(1993): Lodi A+, Contact Dermatitis 29(2), 97 (SS in antifungal
cream)
Eczema
(1998): Agard C+, Rev Mal Respir 15(4), 537
Edema
(1997): Nagayama H+, JDermatol24(10), 675 (SB in Tathion
eye drops)
(1992): Hyndiuk RA+, Lens Eye Toxic Res 9(3–4), 331 (in
intraocular epinephrine)
Erythema
(1997): Nagayama H+, JDermatol24(10), 675 (SB in Tathion
eye drops)
Facial edema
(2003): Vally H+, Addict Biol 8(1), 3
Lichen planus
Pruritus
(2003): Vally H+, Addict Biol 8(1), 3
Rash (sic)
(1998): Arai Y+, Arerugi 47(11), 1163 (16.7%) (in foods)
(1995): Lester MR, JAmCollNutr14(3), 229
Sensitivity
(2002): Harrison DA+, Contact Dermatitis 46(5), 310 (SM in
clobetasone)
(2002): Vally H+, Thorax 57(7), 569
(1999): Heshmati S+, Contact Dermatitis 41(3), 166 (SM in
hydrocortisone cream)
(1991): Frick WE+, JAsthma28(3), 221
Urticaria
(1998): Arai Y+, Arerugi 47(11), 1163 (36.7%) (in foods)
(1993): Belchi-Hernandez J+, Ann Allergy 71(3), 230
(1993): Wuthrich B, Ann Allergy 71(4), 379 (in foods)
(1993): Wuthrich B+, Dermatology 187(4), 290
(1990): Sokol WN+, Ann Allergy 65(3), 233 (SM)
Vasculitis
(1993): Wuthrich B, Ann Allergy 71(4), 379 (in foods)
Mucosal
Burning mouth syndrome
(1996): Levanti C+, Acta Derm Venereol 76(2), 158 (SM)
Eyes
Eyelid dermatitis
(2006): Seitz CS+, Contact Dermatitis 55(4), 249 [SM]
Rhinoconjunctivitis
(1993): Valero AL+, Allergol Immunopathol (Madr) 21(6), 221
(SB, SM)
Other
Abdominal pain
Anaphylactoid reactions/Anaphylaxis
(2000): Reus KE+, Ned Tijdschr Geneeskd 144(38), 1836 (in
foods)
(1996): Miltgen J+, Rev Pneumol Clin 52(6), 363 (PM)
(1993): Wuthrich B+, Dermatology 187(4), 290
(1992): Smolinske SC, J Toxicol Clin Toxicol 30(4), 597 (in local
anesthetics, gentamicin, metoclopramide, doxycycline,
vitamin B complex)
(1991): Soulat JM+, Cah Anesthesiol 39(4), 257 (in local
anesthetic with epinephrine)
(1983): Schwartz HJ, J Allergy Clin Immunol 71, 487
(1982): Twarog FJ+, JAMA 248, 2030 (in isoetharine)
(1981): Stevenson DD+, J Allergy Clin Immunol 68, 26
Cough
(2003): Vally H+, Addict Biol 8(1), 3
Death
(1986): FDA Fed Reg 51, 25021–25026
(1984): FDA Drug Bull 14, 24
Hot flashes
Hypersensitivity
(2003): Stormont JM+, Ann Allergy Asthma Immunol 91(3), 314
(1998): Arai Y+, Arerugi 47(11), 1163 (36.7%) (in foods)
(1996): Sonneville A, Allerg Immunol (Paris) 28(7), 246 (in E 220–
E 227)
(1995): Hallstrom H, Lakartidningen 92(4), 295
SULINDAC
Trade names: Aflodac; Algocetil; APO-Sulin; Arthrocine;
Clinoril; Mobilin; Novo-Sundac; Sulene; Sulic; Suloril
Indications: Arthritis
Category: Non-steroidal anti-inflammatory
Half-life: 7.8–16.4 hours
Clinically important, potentially hazardous interactions
with: methotrexate, warfarin
Reactions
Skin
Angioedema (